close

Enter

Log in using OpenID

Pharmaceutical Anti-counterfeiting Technologies Market

embed
Pharmaceutical Anti-counterfeiting Technologies
Market - Size, Share, Growth, Outlook, and
Opportunity Analysis, 2018-2026
Pharmaceutical products are one of the most vulnerable goods for counterfeiting practices worldwide.
Counterfeiting practices involve substitution of original medicine with substandard drug containing
toxic substance or no active ingredient at all. Anti-counterfeiting technologies are applied to nullify
adverse impact on health of patients, which may lead to death of patient in extreme cases.
Pharmaceutical industry has one of the highly complex supply chain management network, which
makes it relatively difficult to track products from end to end platform, thereby increasing demand for
counterfeiting practice.
Unlike other products in which counterfeiting practices could be identified with visual appearance of
the product by the end user, pharmaceutical products could not be identified for their spurious content
by the end user or other stake holder. Moreover, various patented products of high price are
counterfeited with spurious content to gain high profit. Anti-counterfeiting technologies consist of
different types such as track and trace technologies, cohort technologies, overt technologies, and
forensic technologies. Drugs that are commonly counterfeited include birth control drugs, antimalarial, and other lifesaving drugs. Although there is a rapid change in technology landscape such
as availability of smartphones, burden of anti-counterfeiting practices are increasingly shared by the
end users.
Request Sample Copy of Research Report:
https://www.coherentmarketinsights.com/insight/request-sample/1747
Market Dynamics
Pharmaceutical anti-counterfeiting technologies market is majorly driven by the increasing
incidence of counterfeiting medicines affecting patient health and overall human capital.
According to the International Trade Administration Top Market Reports on Pharmaceuticals
published in 2016, the global market for counterfeit drugs valued at number of US$ 75 - 200
billion, which is a serious threat to the health of people worldwide. In 2017, the Pharmaceutical
Security Institute (PSI) report stated a rise in drug diversion incidents around the world, which
includes diversion of medicines supplied for compassionate use.
Regional Insights
On the basis of region, the global pharmaceutical anti-counterfeiting technologies market is
segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North
America holds a dominant position in the market due to rising number of counterfeit drugs and
stringent regulations related to counterfeit drugs. It is observed that the FDA seized nearly US$
73 million in counterfeit drugs in the year 2014. Moreover, the opioid addiction has led to
increased levels of counterfeit opioids such as fentanyl. The U.S. enacted legislations such as the
U.S. Drug Supply Chain Security Act (DSCSA) in 2017 that mandates pharmaceutical
manufacturers to identify pharmaceuticals at the unit package level, in order to trace the
product within the supply chain. This is done to prevent pharmaceutical product counterfeiting.
Moreover, Asia Pacific is expected to witness significant growth in the market over the forecast
period due to the maximum number of counterfeit drugs available in this region. According to
The World Health Organization (WHO) fact sheet 2017, around 1 in 10 medical products used in
low- and middle-income economies are either substandard or falsified and up to 30 per cent of
branded drugs sold in these economies are counterfeit. According to the Pharmaceutical Security
Institute in 2017, maximum arrest (51%) cases in association with the counterfeiting of
pharmaceuticals are observed in Asia Pacific.
Report includes chapters which deeply display the following deliverable about industry :
• Pharmaceutical Anti-counterfeiting Technologies Market Research Objective and Assumption
• Pharmaceutical Anti-counterfeiting Technologies Market Purview - Report Description, Executive
Summary, and Coherent Opportunity Map (COM)
• Pharmaceutical Anti-counterfeiting Technologies Market Dynamics, Regulations, and Trends
Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New
system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Pharmaceutical Anti-counterfeiting Technologies Market, By Regions
• Pharmaceutical Anti-counterfeiting Technologies Market Competition by Manufacturers including
Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and
Product Type.
• Pharmaceutical Anti-counterfeiting Technologies Market Manufacturers Profiles/Analysis including
Company Basic Information, Manufacturing Base and Its Competitors.
• Pharmaceutical Anti-counterfeiting Technologies Market Manufacturing Cost Analysis including Key
Raw Materials and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning
and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Pharmaceutical Anti-counterfeiting Technologies Market Forecast including Production,
Consumption, Import and Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Key players operating in the pharmaceutical anti-counterfeiting technologies market include
Alien Technology, Alpvision, Robert Bosch GmbH, 3M Company, Angstrom Technologies,
Thermo Fisher Scientific, Authentix, Inc., Avery Dennison Corporation, Colorcon, Covectra,
and Everest Holovisions Ltd.
Inquire Here Before Purchase:
https://www.coherentmarketinsights.com/insight/talk-to-analyst/1747
Market Taxonomy
On the basis of product type, the global pharmaceutical anti-counterfeiting technologies market
is segmented into:
•
•
•
•
•
•
•
RFID
Bar coding
QR Coding
Holography
Security Ink
Taggants
Others
On the basis of technology, the global pharmaceutical anti-counterfeiting technologies market is
segmented into:
•
•
•
•
•
Overt Technologies
Cohort Technologies
Forensic Technologies
Track and Trace Technologies
Others
On the basis of geography, the global pharmaceutical anti-counterfeiting technologies market is
segmented into:
•
•
•
•
North America
Latin America
Europe
Asia Pacific
• Middle East
• Africa
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
Author
Rushikesh
Rushikesh83   documents Email
Document
Category
Health and Medicine
Views
0
File Size
167 KB
Tags
anti
1/--pages
Report inappropriate content